Humanised anti-PTHrP antibody

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHumanised anti-PTHrP antibody
Drug Alias NameCALAnti-PTHrP humanised monoclonal antibody
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionParathyroid hormone receptor antagonists
TargetsParathyroid hormone receptor
Therapy Area/IndicationsHypercalcemiaNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypercalcemiaNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A